{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T18:39:28Z","timestamp":1722019168273},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J CARS"],"DOI":"10.1007\/s11548-022-02662-8","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T01:05:59Z","timestamp":1654131959000},"page":"1867-1877","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification"],"prefix":"10.1007","volume":"17","author":[{"given":"Gulnur","family":"Ungan","sequence":"first","affiliation":[]},{"given":"Anne-Flore","family":"Lavandier","sequence":"additional","affiliation":[]},{"given":"Jacques","family":"Rouanet","sequence":"additional","affiliation":[]},{"given":"Constance","family":"Hordonneau","sequence":"additional","affiliation":[]},{"given":"Benoit","family":"Chauveau","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Louis","family":"Boyer","sequence":"additional","affiliation":[]},{"given":"Jean-Marc","family":"Garcier","sequence":"additional","affiliation":[]},{"given":"Sandrine","family":"Mansard","sequence":"additional","affiliation":[]},{"given":"Adrien","family":"Bartoli","sequence":"additional","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0002-4246-5688","authenticated-orcid":false,"given":"Benoit","family":"Magnin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"2662_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S (2018) Melanoma. The Lancet 392:971\u2013984. https:\/\/doi.org\/10.1016\/S0140-6736(18)31559-9","journal-title":"The Lancet"},{"key":"2662_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1185\/03007995.2015.1021904","volume":"31","author":"X Song","year":"2015","unstructured":"Song X, Zhao Z, Barber B, Farr AM, Ivanov B, Novich M (2015) Overall survival in patients with metastatic melanoma. Curr Med Res Opin 31:987\u2013991. https:\/\/doi.org\/10.1185\/03007995.2015.1021904","journal-title":"Curr Med Res Opin"},{"key":"2662_CR3","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","volume":"371","author":"J Larkin","year":"2014","unstructured":"Larkin J, Ascierto PA, Dr\u00e9no B, Atkinson V, Liszkay G, Maio M, Mandal\u00e0 M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Dutriaux C, Garbe C, Sovak MA, Chang I, Choong N, Hack SP, McArthur GA, Ribas A (2014) Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med 371:1867\u20131876. https:\/\/doi.org\/10.1056\/NEJMoa1408868","journal-title":"N Engl J Med"},{"key":"2662_CR4","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank CU, Hamid O, Mateus C, Shapira-Frommer R, Kosh M, Zhou H, Ibrahim N, Ebbinghaus S, Ribas A (2015) KEYNOTE-006 investigators, Pembrolizumab versus Ipilimumab in Advanced Melanoma. N Engl J Med 372:2521\u20132532. https:\/\/doi.org\/10.1056\/NEJMoa1503093","journal-title":"N Engl J Med"},{"key":"2662_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebb\u00e9 C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Arance A, Schmidt H, Schadendorf D, Gogas H, Lundgren-Eriksson L, Horak C, Sharkey B, Waxman IM, Atkinson V, Ascierto PA (2015) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372:320\u2013330. https:\/\/doi.org\/10.1056\/NEJMoa1412082","journal-title":"N Engl J Med"},{"key":"2662_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/14740338.2015.1021774","volume":"14","author":"J Martin-Liberal","year":"2015","unstructured":"Martin-Liberal J, Kordbacheh T, Larkin J (2015) Safety of pembrolizumab for the treatment of melanoma. Expert Opin Drug Saf 14:957\u2013964. https:\/\/doi.org\/10.1517\/14740338.2015.1021774","journal-title":"Expert Opin Drug Saf"},{"key":"2662_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s13566-015-0219-2","volume":"4","author":"SM Hiniker","year":"2015","unstructured":"Hiniker SM, Maecker HT, Knox SJ (2015) Predictors of clinical response to immunotherapy with or without radiotherapy. J Radiat Oncol 4:339\u2013345. https:\/\/doi.org\/10.1007\/s13566-015-0219-2","journal-title":"J Radiat Oncol"},{"key":"2662_CR8","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1158\/1078-0432.CCR-16-0127","volume":"22","author":"B Weide","year":"2016","unstructured":"Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, Mangana J, Schilling B, Di Giacomo AM, Brenner N, K\u00e4hler K, Heinzerling L, Gutzmer R, Bender A, Gebhardt C, Romano E, Meier F, Martus P, Maio M, Blank C, Schadendorf D, Dummer R, Ascierto PA, Hospers G, Garbe C, Wolchok JD (2016) Baseline biomarkers for outcome of melanoma patients treated with pembrolizumab. Clin Cancer Res 22:5487\u20135496. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0127","journal-title":"Clin Cancer Res"},{"key":"2662_CR9","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/bjc.2017.70","volume":"116","author":"A Nosrati","year":"2017","unstructured":"Nosrati A, Tsai KK, Goldinger SM, Tumeh P, Grimes B, Loo K, Algazi AP, Nguyen-Kim TDL, Levesque M, Dummer R, Hamid O, Daud A (2017) Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy. Br J Cancer 116:1141\u20131147. https:\/\/doi.org\/10.1038\/bjc.2017.70","journal-title":"Br J Cancer"},{"key":"2662_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/2050640615601603","volume":"4","author":"S-X Rao","year":"2016","unstructured":"Rao S-X, Lambregts DM, Schnerr RS, Beckers RC, Maas M, Albarello F, Riedl RG, Dejong CH, Martens MH, Heijnen LA, Backes WH, Beets GL, Zeng M-S, Beets-Tan RG (2016) CT texture analysis in colorectal liver metastases: a better way than size and volume measurements to assess response to chemotherapy? United Eur Gastroenterol J 4:257\u2013263. https:\/\/doi.org\/10.1177\/2050640615601603","journal-title":"United Eur Gastroenterol J"},{"key":"2662_CR11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00330-016-4470-8","volume":"27","author":"B Ganeshan","year":"2017","unstructured":"Ganeshan B, Miles KA, Babikir S, Shortman R, Afaq A, Ardeshna KM, Groves AM, Kayani I (2017) CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin\u2019s and aggressive non-hodgkin\u2019s lymphomas. Eur Radiol 27:1012\u20131020. https:\/\/doi.org\/10.1007\/s00330-016-4470-8","journal-title":"Eur Radiol"},{"key":"2662_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx055","author":"V Verma","year":"2017","unstructured":"Verma V, Simone CB, Krishnan S, Lin SH, Yang J, Hahn SM (2017) The rise of radiomics and implications for oncologic management. JNCI J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djx055","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2662_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1148\/radiol.12120254","volume":"266","author":"F Ng","year":"2013","unstructured":"Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V (2013) Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266:177\u2013184. https:\/\/doi.org\/10.1148\/radiol.12120254","journal-title":"Radiology"},{"key":"2662_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1148\/radiol.2502071879","volume":"250","author":"KA Miles","year":"2009","unstructured":"Miles KA, Ganeshan B, Griffiths MR, Young RCD, Chatwin CR (2009) Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology 250:444\u2013452. https:\/\/doi.org\/10.1148\/radiol.2502071879","journal-title":"Radiology"},{"key":"2662_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1148\/radiol.2018171320","volume":"288","author":"S Mul\u00e9","year":"2018","unstructured":"Mul\u00e9 S, Thiefin G, Costentin C, Durot C, Rahmouni A, Luciani A, Hoeffel C (2018) Advanced hepatocellular carcinoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with sorafenib. Radiology 288:445\u2013455. https:\/\/doi.org\/10.1148\/radiol.2018171320","journal-title":"Radiology"},{"key":"2662_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40644-016-0065-5","volume":"16","author":"KA Miles","year":"2016","unstructured":"Miles KA (2016) How to use CT texture analysis for prognostication of non-small cell lung cancer, Cancer Imaging Off. Publ Int Cancer Imaging Soc 16:10. https:\/\/doi.org\/10.1186\/s40644-016-0065-5","journal-title":"Publ Int Cancer Imaging Soc"},{"key":"2662_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/RLI.0000000000000174","volume":"50","author":"SY Ahn","year":"2015","unstructured":"Ahn SY, Park CM, Park SJ, Kim HJ, Song C, Lee SM, McAdams HP, Goo JM (2015) Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy. Invest Radiol 50:719\u2013725. https:\/\/doi.org\/10.1097\/RLI.0000000000000174","journal-title":"Invest Radiol"},{"key":"2662_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00330-011-2319-8","volume":"22","author":"B Ganeshan","year":"2012","unstructured":"Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22:796\u2013802. https:\/\/doi.org\/10.1007\/s00330-011-2319-8","journal-title":"Eur Radiol"},{"key":"2662_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/RCT.0000000000000239","volume":"39","author":"K Hayano","year":"2015","unstructured":"Hayano K, Tian F, Kambadakone AR, Yoon SS, Duda DG, Ganeshan B, Sahani DV (2015) Texture analysis of non-contrast-enhanced computed tomography for assessing angiogenesis and survival of soft tissue sarcoma. J Comput Assist Tomogr 39:607\u2013612. https:\/\/doi.org\/10.1097\/RCT.0000000000000239","journal-title":"J Comput Assist Tomogr"},{"key":"2662_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.crad.2011.08.012","volume":"67","author":"B Ganeshan","year":"2012","unstructured":"Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157\u2013164. https:\/\/doi.org\/10.1016\/j.crad.2011.08.012","journal-title":"Clin Radiol"},{"key":"2662_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1148\/radiol.13122869","volume":"270","author":"C Yip","year":"2014","unstructured":"Yip C, Landau D, Kozarski R, Ganeshan B, Thomas R, Michaelidou A, Goh V (2014) Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. Radiology 270:141\u2013148. https:\/\/doi.org\/10.1148\/radiol.13122869","journal-title":"Radiology"},{"key":"2662_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1148\/radiol.13130110","volume":"269","author":"H Zhang","year":"2013","unstructured":"Zhang H, Graham CM, Elci O, Griswold ME, Zhang X, Khan MA, Pitman K, Caudell JJ, Hamilton RD, Ganeshan B, Smith AD (2013) Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy. Radiology 269:801\u2013809. https:\/\/doi.org\/10.1148\/radiol.13130110","journal-title":"Radiology"},{"key":"2662_CR23","doi-asserted-by":"publisher","first-page":"e0207455","DOI":"10.1371\/journal.pone.0207455","volume":"13","author":"S Ramella","year":"2018","unstructured":"Ramella S, Fiore M, Greco C, Cordelli E, Sicilia R, Merone M, Molfese E, Miele M, Cornacchione P, Ippolito E, Iannello G, D\u2019Angelillo RM, Soda P (2018) A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients. PLoS ONE 13:e0207455. https:\/\/doi.org\/10.1371\/journal.pone.0207455","journal-title":"PLoS ONE"},{"key":"2662_CR24","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.ejrad.2016.08.014","volume":"85","author":"SJ Ahn","year":"2016","unstructured":"Ahn SJ, Kim JH, Park SJ, Han JK (2016) Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol 85:1867\u20131874. https:\/\/doi.org\/10.1016\/j.ejrad.2016.08.014","journal-title":"Eur J Radiol"},{"key":"2662_CR25","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00261-014-0318-3","volume":"40","author":"F Tian","year":"2015","unstructured":"Tian F, Hayano K, Kambadakone AR, Sahani DV (2015) Response assessment to neoadjuvant therapy in soft tissue sarcomas: using CT texture analysis in comparison to tumor size, density, and perfusion, Abdom. Imaging 40:1705\u20131712. https:\/\/doi.org\/10.1007\/s00261-014-0318-3","journal-title":"Imaging"},{"key":"2662_CR26","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1007\/s00330-013-2965-0","volume":"23","author":"M Ravanelli","year":"2013","unstructured":"Ravanelli M, Farina D, Morassi M, Roca E, Cavalleri G, Tassi G, Maroldi R (2013) Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy. Eur Radiol 23:3450\u20133455. https:\/\/doi.org\/10.1007\/s00330-013-2965-0","journal-title":"Eur Radiol"},{"key":"2662_CR27","doi-asserted-by":"publisher","first-page":"121904","DOI":"10.1118\/1.4900821","volume":"41","author":"T Knogler","year":"2014","unstructured":"Knogler T, Thomas K, El-Rabadi K, Karem E-R, Weber M, Michael W, Karanikas G, Georgios K, Mayerhoefer ME, Marius Erik M (2014) Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: comparison with F-18-FDG PET. Med Phys 41:121904. https:\/\/doi.org\/10.1118\/1.4900821","journal-title":"Med Phys"},{"key":"2662_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1148\/radiol.2018180946","volume":"290","author":"HC Kniep","year":"2019","unstructured":"Kniep HC, Madesta F, Schneider T, Hanning U, Sch\u00f6nfeld MH, Sch\u00f6n G, Fiehler J, Gauer T, Werner R, Gellissen S (2019) Radiomics of Brain MRI: utility in prediction of metastatic tumor type. Radiology 290:479\u2013487. https:\/\/doi.org\/10.1148\/radiol.2018180946","journal-title":"Radiology"},{"key":"2662_CR29","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1007\/s00330-018-5463-6","volume":"28","author":"R Ortiz-Ram\u00f3n","year":"2018","unstructured":"Ortiz-Ram\u00f3n R, Larroza A, Ruiz-Espa\u00f1a S, Arana E, Moratal D (2018) Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study. Eur Radiol 28:4514\u20134523. https:\/\/doi.org\/10.1007\/s00330-018-5463-6","journal-title":"Eur Radiol"},{"key":"2662_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1148\/radiol.12112428","volume":"266","author":"B Ganeshan","year":"2013","unstructured":"Ganeshan B, Goh V, Mandeville HC, Ng QS, Hoskin PJ, Miles KA (2013) Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 266:326\u2013336. https:\/\/doi.org\/10.1148\/radiol.12112428","journal-title":"Radiology"},{"key":"2662_CR31","doi-asserted-by":"publisher","first-page":"W283","DOI":"10.2214\/AJR.15.14315","volume":"205","author":"AD Smith","year":"2015","unstructured":"Smith AD, Gray MR, del Campo SM, Shlapak D, Ganeshan B, Zhang X, Carson WE (2015) Predicting overall survival in patients with metastatic melanoma on antiangiogenic therapy and recist stable disease on initial posttherapy images using CT texture analysis. Am J Roentgenol 205:W283\u2013W293. https:\/\/doi.org\/10.2214\/AJR.15.14315","journal-title":"Am J Roentgenol"},{"key":"2662_CR32","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1007\/s00330-018-5933-x","volume":"29","author":"C Durot","year":"2019","unstructured":"Durot C, Mul\u00e9 S, Soyer P, Marchal A, Grange F, Hoeffel C (2019) Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab. Eur Radiol 29:3183\u20133191. https:\/\/doi.org\/10.1007\/s00330-018-5933-x","journal-title":"Eur Radiol"},{"key":"2662_CR33","doi-asserted-by":"publisher","first-page":"108688","DOI":"10.1016\/j.ejrad.2019.108688","volume":"121","author":"A Schraag","year":"2019","unstructured":"Schraag A, Klumpp B, Afat S, Gatidis S, Nikolaou K, Eigentler TK, Othman AE (2019) Baseline clinical and imaging predictors of treatment response and overall survival of patients with metastatic melanoma undergoing immunotherapy. Eur J Radiol 121:108688. https:\/\/doi.org\/10.1016\/j.ejrad.2019.108688","journal-title":"Eur J Radiol"},{"key":"2662_CR34","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3389\/fonc.2020.01524","volume":"10","author":"Z Wang","year":"2020","unstructured":"Wang Z, Mao L, Zhou Z, Si L, Zhu H, Chen X, Zhou M, Sun Y, Guo J (2020) Pilot study of CT-based radiomics model for early evaluation of response to immunotherapy in patients with metastatic melanoma. Front Oncol 10:1524. https:\/\/doi.org\/10.3389\/fonc.2020.01524","journal-title":"Front Oncol"},{"key":"2662_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1023\/A:1022627411411","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn 20:273\u2013297. https:\/\/doi.org\/10.1023\/A:1022627411411","journal-title":"Mach Learn"},{"key":"2662_CR36","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s00330-020-07250-5","volume":"31","author":"H Chu","year":"2021","unstructured":"Chu H, Liu Z, Liang W, Zhou Q, Zhang Y, Lei K, Tang M, Cao Y, Chen S, Peng S, Kuang M (2021) Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma. Eur Radiol 31:2368\u20132376. https:\/\/doi.org\/10.1007\/s00330-020-07250-5","journal-title":"Eur Radiol"},{"key":"2662_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08104-4","author":"B Badic","year":"2021","unstructured":"Badic B, Da-ano R, Poirot K, Jaouen V, Magnin B, Gagni\u00e8re J, Pezet D, Hatt M, Visvikis D (2021) Prediction of recurrence after surgery in colorectal cancer patients using radiomics from diagnostic contrast-enhanced computed tomography: a two-center study. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-021-08104-4","journal-title":"Eur Radiol"},{"key":"2662_CR38","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00330-018-5730-6","volume":"29","author":"P Yin","year":"2019","unstructured":"Yin P, Mao N, Zhao C, Wu J, Sun C, Chen L, Hong N (2019) Comparison of radiomics machine-learning classifiers and feature selection for differentiation of sacral chordoma and sacral giant cell tumour based on 3D computed tomography features. Eur Radiol 29:1841\u20131847. https:\/\/doi.org\/10.1007\/s00330-018-5730-6","journal-title":"Eur Radiol"},{"key":"2662_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13014-018-1140-9","volume":"13","author":"W Sun","year":"2018","unstructured":"Sun W, Jiang M, Dang J, Chang P, Yin F-F (2018) Effect of machine learning methods on predicting NSCLC overall survival time based on Radiomics analysis. Radiat Oncol 13:197. https:\/\/doi.org\/10.1186\/s13014-018-1140-9","journal-title":"Radiat Oncol"},{"key":"2662_CR40","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, Reuz\u00e9 S, Goya-Outi J, Robert C, Pellot-Barakat C, Soussan M, Frouin F, Buvat I (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78:4786\u20134789. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0125","journal-title":"Cancer Res"},{"key":"2662_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP (2002) SMOTE: synthetic minority over-sampling technique. J Artif Intell Res 16:321\u2013357. https:\/\/doi.org\/10.1613\/jair.953","journal-title":"J Artif Intell Res"},{"key":"2662_CR42","doi-asserted-by":"publisher","DOI":"10.1201\/9780429258589","volume-title":"Practical statistics for medical research","author":"DG Altman","year":"1990","unstructured":"Altman DG (1990) Practical statistics for medical research. CRC Press, Florida"},{"key":"2662_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, Bouter LM, de Vet HCW (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34\u201342. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.03.012","journal-title":"J Clin Epidemiol"},{"key":"2662_CR44","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1200\/JCO.2015.64.0391","volume":"34","author":"FS Hodi","year":"2016","unstructured":"Hodi FS, Hwu W-J, Kefford R, Weber JS, Daud A, Hamid O, Patnaik A, Ribas A, Robert C, Gangadhar TC, Joshua AM, Hersey P, Dronca R, Joseph R, Hille D, Xue D, Li XN, Kang SP, Ebbinghaus S, Perrone A, Wolchok JD (2016) Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with pembrolizumab. J Clin Oncol 34:1510\u20131517. https:\/\/doi.org\/10.1200\/JCO.2015.64.0391","journal-title":"J Clin Oncol"},{"key":"2662_CR45","doi-asserted-by":"publisher","first-page":"13087","DOI":"10.1038\/srep13087","volume":"5","author":"C Parmar","year":"2015","unstructured":"Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJWL (2015) Machine learning methods for quantitative radiomic biomarkers. Sci Rep 5:13087. https:\/\/doi.org\/10.1038\/srep13087","journal-title":"Sci Rep"},{"key":"2662_CR46","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.jtho.2016.07.002","volume":"11","author":"S Hawkins","year":"2016","unstructured":"Hawkins S, Wang H, Liu Y, Garcia A, Stringfield O, Krewer H, Li Q, Cherezov D, Gatenby RA, Balagurunathan Y, Goldgof D, Schabath MB, Hall L, Gillies RJ (2016) Predicting malignant nodules from screening CTs. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 11:2120\u20132128. https:\/\/doi.org\/10.1016\/j.jtho.2016.07.002","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"2662_CR47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fonc.2015.00272","volume":"5","author":"C Parmar","year":"2015","unstructured":"Parmar C, Grossmann P, Rietveld D, Rietbergen MM, Lambin P, Aerts HJWL (2015) Radiomic machine-learning classifiers for prognostic biomarkers of head and neck cancer. Front Oncol 5:272. https:\/\/doi.org\/10.3389\/fonc.2015.00272","journal-title":"Front Oncol"},{"issue":"1","key":"2662_CR48","first-page":"3133","volume":"15","author":"M Fernandez-Delgado","year":"2014","unstructured":"Fernandez-Delgado M, Cernadas E, Barro S, Amorim D (2014) Do we need hundreds of classifiers to solve real world classification problems? J Mach Learn Res 15(1):3133\u20133181","journal-title":"J Mach Learn Res"},{"key":"2662_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13042-012-0068-x","volume":"4","author":"AB Musa","year":"2013","unstructured":"Musa AB (2013) Comparative study on classification performance between support vector machine and logistic regression. Int J Mach Learn Cybern 4:13\u201324. https:\/\/doi.org\/10.1007\/s13042-012-0068-x","journal-title":"Int J Mach Learn Cybern"},{"key":"2662_CR50","first-page":"25","volume":"1","author":"K Kirasich","year":"2018","unstructured":"Kirasich K, Smith T, Sadler B (2018) Random forest vs logistic regression: binary classification for heterogeneous datasets. SMU Data Science Review 1:25","journal-title":"SMU Data Science Review"},{"key":"2662_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12911-019-1004-8","volume":"19","author":"S Uddin","year":"2019","unstructured":"Uddin S, Khan A, Hossain ME, Moni MA (2019) Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak 19:281. https:\/\/doi.org\/10.1186\/s12911-019-1004-8","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["International Journal of Computer Assisted Radiology and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11548-022-02662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11548-022-02662-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11548-022-02662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T14:16:07Z","timestamp":1662992167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11548-022-02662-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2662"],"URL":"https:\/\/doi.org\/10.1007\/s11548-022-02662-8","relation":{},"ISSN":["1861-6429"],"issn-type":[{"value":"1861-6429","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}